TOLL-LIKE RECEPTORS REGULATION OF VIRAL INFECTION AND DISEASE
Viral sensing, following either direct fusion with the plasma membrane, or receptor-mediated endocytosis, initiates innate immunity and regulates virus-induced disease. Depending upon the viral genome content and entry mechanism, viral nucleic acids, or replicative intermediates, are recognized by one of the cellular sensing molecules such as DAI, RIG-I/MDA5, or one of the endosomal TLRs (3, 7, 9), and an innate anti-viral program is activated. Recognition of RNA viruses (RIG-I/MDA5) and DNA viruses (DAI) by the intracellular sensors stimulates innate immunity that limits replication and promotes protection. In the case of the TLR pathway, viral sensing by endosomal TLRs may lead to a protective innate and adaptive immune response. For certain ssRNA viruses, the delivery of viral PAMP to the late endosome/lysosome compartment is mediated by autophagy. Conversely, these interactions may exacerbate virus-induced disease, leading to a poor outcome for the host. Likewise, plasma membrane TLRs may also promote virus-induced inflammation. Together, these examples highlight how viral-TLR interactions affect virus-induced disease both in a positive and negative fashion.
Publication
TOLL-LIKE RECEPTORS REGULATION OF VIRAL INFECTION AND DISEASE. () Joseph M. Thompson, et al. Adv Drug Deliv Rev. ;60(7):786-794. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TLR1 | TLR1 | ncbigene_symbol | TLR1 | 7096 |
| Homo sapiens | Primates | TLR1/2/4/6 | TLR2 | ncbigene_symbol | TLR2 | 7097 |
| Homo sapiens | Primates | TLR1/2/4/6 | TLR6 | ncbigene_symbol | TLR6 | 10333 |
| Homo sapiens | Primates | TLR1/2/4/6 | TLR4 | ncbigene_symbol | TLR4 | 7099 |
| Homo sapiens | Primates | RIG-I/MDA5 | MDA5 | ncbigene_synonym | IFIH1 | 64135 |
| Homo sapiens | Primates | RIG-I/MDA5 | RIG-I | ncbigene_synonym | RIGI | 23586 |
| Homo sapiens | Primates | DAI | DAI | ncbigene_synonym | ZBP1 | 81030 |
| Homo sapiens | Primates | MAVS | MAVS | ncbigene_symbol | MAVS | 57506 |
| Homo sapiens | Primates | limit | LIMIT | ncbigene_synonym | GBP1P1 | 400759 |
| Homo sapiens | Primates | TLR3 | TLR3 | ncbigene_symbol | TLR3 | 7098 |
| Homo sapiens | Primates | TLR3/7/9 | TLR9 | ncbigene_symbol | TLR9 | 54106 |
| Homo sapiens | Primates | TLR3/7/9 | TLR7 | ncbigene_symbol | TLR7 | 51284 |
| Mus musculus | Rodents | TLR1 | TLR1 | ncbigene_symbol | Tlr1 | 21897 |
| Mus musculus | Rodents | TLR1/2/4/6 | TLR2 | ncbigene_symbol | Tlr2 | 24088 |
| Mus musculus | Rodents | TLR1/2/4/6 | TLR6 | ncbigene_symbol | Tlr6 | 21899 |
| Mus musculus | Rodents | TLR1/2/4/6 | TLR4 | ncbigene_symbol | Tlr4 | 21898 |
| Mus musculus | Rodents | RIG-I/MDA5 | MDA5 | ncbigene_synonym | Ifih1 | 71586 |
| Mus musculus | Rodents | RIG-I/MDA5 | RIG-I | ncbigene_synonym | Rigi | 230073 |
| Mus musculus | Rodents | DAI | DAI | ncbigene_synonym | Zbp1 | 58203 |
| Mus musculus | Rodents | MAVS | MAVS | ncbigene_symbol | Mavs | 228607 |
| Mus musculus | Rodents | TLR3 | TLR3 | ncbigene_symbol | Tlr3 | 142980 |
| Mus musculus | Rodents | TLR3/7/9 | TLR9 | ncbigene_symbol | Tlr9 | 81897 |
| Mus musculus | Rodents | TLR3/7/9 | TLR7 | ncbigene_symbol | Tlr7 | 170743 |
| Danio rerio | Vertebrates | TLR1 | TLR1 | ncbigene_symbol | tlr1 | 403127 |
| Danio rerio | Vertebrates | TLR1/2/4/6 | TLR2 | ncbigene_symbol | tlr2 | 403125 |
| Danio rerio | Vertebrates | RIG-I/MDA5 | RIG-I | ncbigene_synonym | rigi | 100333797 |
| Danio rerio | Vertebrates | MAVS | MAVS | ncbigene_symbol | mavs | 562867 |
| Danio rerio | Vertebrates | TLR3 | TLR3 | ncbigene_symbol | tlr3 | 403126 |
| Danio rerio | Vertebrates | TLR3/7/9 | TLR9 | ncbigene_symbol | tlr9 | 403128 |
| Danio rerio | Vertebrates | TLR3/7/9 | TLR7 | ncbigene_symbol | tlr7 | 100534776 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|